Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). (Q46805282)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). |
scientific article |
Statements
1 reference
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). (English)
1 reference
Kamal M F Itani
1 reference
John Weigelt
1 reference
Jim Z Li
1 reference
Sandeep Duttagupta
1 reference
10 November 2005
1 reference
26
1 reference
6
1 reference
442-448
1 reference
Identifiers
1 reference
1 reference